Yttrium-90 Microsphere Radioembolotherapy of Hepatic Metastatic Neuroendocrine Carcinomas after Hepatic Arterial Embolization

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 1, 2008, Pages 145-151

  Murthy, Ravi ^a   Kamat, Paresh ^a   Nunez, Rodolfo ^a   Madoff, David C ^a   Gupta, Sanjay ^a   Salem, Riad ^b   Yao, James C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; RESIN; YTTRIUM 90;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN CANCER; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCRINE TUMOR; FEMALE; HUMAN; LABORATORY TEST; LIVER METASTASIS; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

AGED; ANGIOGRAPHY; BRACHYTHERAPY; CARCINOMA, NEUROENDOCRINE; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 37549056586     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.09.006     Document Type: Article

References (17)

1. Chamberlain R.S., Canes D., Brown K.T., et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 190 (2000) 432-445
2. Madoff D.C., Gupta S., Ahrar K., Murthy R., and Yao J.C. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17 (2006) 1235-1249
3. Modlin I.M., Lye K.D., and Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 (2003) 934-959 15
4. Talamonti M.S., Stuart K.E., and Yao J.C. Neuroendocrine tumors of the gastrointestinal tract: how aggressive should we be?. American Society of Clinical Oncology 2004 Education Book (2004), American Society of Clinical Oncology, Alexandria, VA 206-215
5. Gray B., Van Hazel G., Hope M., et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 (2001) 1711-1720
6. Carr B. Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 10 suppl 1 (2004) S107-S110
7. Coldwell D. Use of yttrium-90 SIR-Spheres to treat unresectable metastatic neuroendocrine tumors to the liver. In: Program and Abstracts of the World Congress on Gastrointestinal Cancer; June 15-18, 2005; Barcelona, Spain. Abstract O-002.
8. King J, Glenn D, Quinn R, Janssen J, Liauw W. Pilot study of SIR Spheres® in liver metastases from neuroendocrine cancer (NETLM). In: Program and Abstracts of the Third European Neuroendocrine Tumour Society (ENTS) Conference; June 24-26, 2006; Prague, Czech Republic. Abstract C28.
9. King J, Glenn D, Quinn R, Janssen J, Liauw W. SIR Spheres® for liver metastases from neuroendocrine tumours (NET LM). Presented at the World Congress on Gastrointestinal Cancer; June 15-18, 2005; Barcelona, Spain. Poster 090.
10. Salem R., and Thurston K.G. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations. J Vasc Interv Radiol 17 (2006) 1251-1278
11. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104 (2005) 1590-1602
12. Blanchard R., Morrow I., and Sutherland J. Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J 40 (1989) 206-210
13. Mantravadi R., Spigos D., Tan W., and Felix E. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142 (1982) 783-786
14. Murthy R, Gupta S, Madoff DC, Nunez RF, Yao J, Szklaruk J. Feasibility of hepatic arterial therapy with yttrium-90 microspheres, SIR-Spheres®, in metastatic neuroendocrine neoplasia with hepatic dominant progression after failure of multiple systemic and hepatic artery therapies. Presented at the Radiological Society of North America; November 27 through December 2, 2005; Chicago, Ill. Abstract SSK03-06:410-411.
15. Herba M., and Thirlwell M. Radioembolization for hepatic metastases. Semin Oncol 29 (2002) 152-159
16. Andrews J., Walker S., Ackermann R., Cotton L., Ensminger W., and Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35 (1994) 1637-1644
17. Kennedy A.S., Dezam W.A., McNeillie P., Overton C., England M., and Sailer S. Fractionation, dose selection, and response of hepatic metastases of neuroendocrine tumors after 90y-microsphere brachytherapy. J Brachytherapy (2006) 103 Abstract 75